Management of chronic obstructive lung disease.
The management of chronic nonspecific lung disease (CNSLD) is a complex matter, influenced by different etiopathogenetic and physiopathological mechanisms. The most significant of these mechanisms have been revealed. Of the different function examinations the respiratory gas analysis appears to be particularly useful in obtaining detailed information. However, the choice of medication still remains of utmost importance. This paper presents a review of the selection criteria for antibiotics, bronchodilator drugs, theophylline derivatives, beta-sympathicomimetics, atropine corticoids, desensitizing substances together with the indication for a correct oxygen therapy.
D000628:Aminophylline / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002908:Chronic Disease; D005100:Expectorants / Q000627:therapeutic use; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D010102:Oxygen Inhalation Therapy; D013566:Sympathomimetics / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005100:Expectorants; D013566:Sympathomimetics; D000628:Aminophylline